• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

    5/16/25 8:35:00 AM ET
    $BLTE
    $COE
    $HCM
    $IH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $BLTE alert in real time by email

    NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Depositary Receipts Virtual Investor Conference ("dbVIC") held May 15th are now available for online viewing.

    VIEW PRESENTATIONS HERE

    The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section.

    May 15th Company Presentations

    Bavarian Nordic A/S ((Nasdaq Copenhagen: BAVA, OTC:BVNRY)
    Viomi Technology Co., Ltd. (NASDAQ:VIOT)
    Infineon Technologies AG ((Xetra: IFX, OTC:IFNNY)
    Clicks Group Ltd. ((JSE: CLS, OTC:CLCGY)
    First Pacific Company Ltd. ((HKEX: 142, OTC:FPAFY)
    HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    51Talk Online Education Group (NYSE:COE)
    Yiren Digital Ltd. (NYSE:YRD)
    ABB Ltd. ((SIX: ABBN, OTC:ABBNY)
    Belite Bio, Inc. (NASDAQ:BLTE)
    Epiroc AB ((Nasdaq Stockholm: EPIA, OTC:EPOAY)
    International Airlines Group ((LSE: IAG, MAD: IAG, OTC:ICAGY)
    BDO Unibank, Inc. ((PSE: BDO, OTC:BDOUY)
    iHuman Inc. (NYSE:IH)



    To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

    About Virtual Investor Conferences®

    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    Media Contact: 

    OTC Markets Group Inc. +1 (212) 896-4428, [email protected]

    Virtual Investor Conferences Contact:

    John M. Viglotti

    SVP Corporate Services, Investor Access

    OTC Markets Group

    (212) 220-2221

    [email protected]



    Primary Logo

    Get the next $BLTE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLTE
    $COE
    $HCM
    $IH

    CompanyDatePrice TargetRatingAnalyst
    HUTCHMED (China) Limited
    $HCM
    5/13/2025Buy → Hold
    HSBC Securities
    Belite Bio Inc
    $BLTE
    12/14/2023$60.00Buy
    Maxim Group
    HUTCHMED (China) Limited
    $HCM
    11/24/2023Hold → Buy
    Deutsche Bank
    Belite Bio Inc
    $BLTE
    7/28/2023$43.00Overweight
    Cantor Fitzgerald
    Belite Bio Inc
    $BLTE
    7/26/2023$25.00Outperform
    SVB Securities
    iHuman Inc.
    $IH
    12/30/2022$3.10Buy
    Citigroup
    Belite Bio Inc
    $BLTE
    8/1/2022$58.00Buy
    H.C. Wainwright
    HUTCHMED (China) Limited
    $HCM
    5/4/2022Buy → Hold
    Deutsche Bank
    More analyst ratings

    $BLTE
    $COE
    $HCM
    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 51Talk Online Education Group to Report First Quarter 2025 Financial Results on Monday, June 9, 2025

      Earnings Call Scheduled for 8:00 a.m. ET on June 9, 2025 SINGAPORE, June 5, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE:COE), a global online education platform with core expertise in English education, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025 on Monday, June 9, 2025, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 9, 2025 (8:00p.m. Singapore/Beijing/Hong Kong time on June 9, 2025). Dial-in details for the earnings conference call are as follows: United States Toll: 1-888-346-8982 International:

      6/5/25 7:00:00 AM ET
      $COE
      Other Consumer Services
      Real Estate
    • Yiren Digital to Report First Quarter 2025 Financial Results on June 12, 2025

      BEIJING, June 5, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in Asia, announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2025 before U.S. market opens on Thursday, June 12, 2025. Yiren Digital's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 12, 2025 (or 8:00 p.m. Beijing/Hong Kong Time on June 12, 2025). Participants who wish to join the call should register online in advance of the conference at: https://dpregister.com/sreg/10200245/ff3e415b7a Once registration is completed, parti

      6/5/25 5:30:00 AM ET
      $YRD
      Finance: Consumer Services
      Finance
    • HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma

      HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801) today jointly announce that the New Drug Application ("NDA") for the combination of fruquintinib and sintilimab for the treatment of patients with locally advanced or metastatic renal cell carcinoma who have failed prior treatment with one tyrosine kinase inhibitor ("TKI") has been accepted for review by the China National Medical Products Administration ("NMPA"). The NDA is supported by data from FRUSICA-2, a randomized, open-label, active-controlled registration study evaluating the effi

      6/4/25 7:45:00 PM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    SEC Filings

    See more
    • SEC Form 6-K filed by HUTCHMED (China) Limited

      6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

      6/5/25 6:25:31 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by HUTCHMED (China) Limited

      6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

      6/2/25 6:03:30 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by HUTCHMED (China) Limited

      6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

      5/30/25 6:06:17 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Leadership Updates

    Live Leadership Updates

    See more
    • HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

      HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:​HCM, HKEX:​13) today announces that Mr Wong Tak Wai (Mr Alvin Wong) is appointed as an Independent Non-executive Director and a member of the Audit Committee of the Company with effect from March 6, 2025. Mr Wong has over 35 years of extensive experience in accounting, auditing and corporate finance. He has acted in a pivotal role in assisting companies with their stock exchange listings and has been instrumental in completing numerous mergers and acquisitions. After a distinguished career spanning more than three decades, Mr Wong retired as

      3/5/25 5:00:00 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Viomi Technology Co., Ltd Appoints New President of Operations to Promote High-quality Business Development

      GUANGZHOU, China, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced the appointment of Mr. Guang Wu as President of Operations, effective December 4, 2024. In this role, Mr. Wu will focus on driving high-quality business development and enhancing operational efficiency. Mr. Wu brings over 20 years of experience in business development and marketing within the domestic home appliances and home furnishing industry. Prior to joining Viomi, he served as Vice President and General Manager of Domestic Marketing at Sleemon Group. Before that, he managed domestic m

      12/4/24 4:00:00 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

      HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:HCM, HKEX:13) today announces that Dr Chaohong Hu (Dr Mary Hu) is appointed as an Independent Non-executive Director and a member of the Technical Committee of the Company with effect from November 21, 2024. Dr Hu has over 20 years of experience in the development of therapeutic antibodies, antibody-drug conjugates, and vaccines. Throughout her career, she has demonstrated strong leadership and innovative capabilities, leading various research and development initiatives. Dr Hu's expertise spans from early-stage discovery to clinical developme

      11/20/24 4:30:00 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Financials

    Live finance-specific insights

    See more
    • 51Talk Online Education Group to Report First Quarter 2025 Financial Results on Monday, June 9, 2025

      Earnings Call Scheduled for 8:00 a.m. ET on June 9, 2025 SINGAPORE, June 5, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE:COE), a global online education platform with core expertise in English education, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025 on Monday, June 9, 2025, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 9, 2025 (8:00p.m. Singapore/Beijing/Hong Kong time on June 9, 2025). Dial-in details for the earnings conference call are as follows: United States Toll: 1-888-346-8982 International:

      6/5/25 7:00:00 AM ET
      $COE
      Other Consumer Services
      Real Estate
    • Yiren Digital to Report First Quarter 2025 Financial Results on June 12, 2025

      BEIJING, June 5, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in Asia, announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2025 before U.S. market opens on Thursday, June 12, 2025. Yiren Digital's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 12, 2025 (or 8:00 p.m. Beijing/Hong Kong Time on June 12, 2025). Participants who wish to join the call should register online in advance of the conference at: https://dpregister.com/sreg/10200245/ff3e415b7a Once registration is completed, parti

      6/5/25 5:30:00 AM ET
      $YRD
      Finance: Consumer Services
      Finance
    • Viomi Technology Co., Ltd Reports Second Half and Full Year 2024 Unaudited Financial Results

      GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced its unaudited financial results for the second half and full year ended December 31, 2024. Second Half 2024 Financial Highlights1 Net revenues2 reached RMB1,282.4 million (US$175.7 million), an increase of 42.8% from RMB897.9 million for the same period of 2023.Net income was RMB56.8 million (US$7.8 million), compared to a net loss of RMB32.0 million for the same period of 2023. Full Year 2024 Financial Highlights Net revenues were RMB2,119.0 million (US$290.3 million), an increase of 29

      3/25/25 7:00:30 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary

    $BLTE
    $COE
    $HCM
    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HUTCHMED downgraded by HSBC Securities

      HSBC Securities downgraded HUTCHMED from Buy to Hold

      5/13/25 3:20:36 PM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Maxim Group initiated coverage on Belite Bio with a new price target

      Maxim Group initiated coverage of Belite Bio with a rating of Buy and set a new price target of $60.00

      12/14/23 8:06:18 AM ET
      $BLTE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HUTCHMED upgraded by Deutsche Bank

      Deutsche Bank upgraded HUTCHMED from Hold to Buy

      11/24/23 7:13:23 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

      SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

      12/17/24 4:07:04 PM ET
      $COE
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

      SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

      11/12/24 6:35:53 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

      SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

      10/10/24 6:45:35 AM ET
      $COE
      Other Consumer Services
      Real Estate